Recent News and Articles on the Keywords: patch + skin + alzheimer  Related to the article below (Last Update: 12/1/2008)

 News results: Standard Version | Text Version | Image Version Results 1 - 4 of 4 for patch skin alzheimer. (0.32 seconds) 
Recent
Archives
  • All dates
  • 2008
  • 2007
  • 2006
  • 1999-2005
  • 1995-98

 Sorted by relevance   Sort by date   Sort by date with duplicates included 
Did you mean: patch + skin + alzheimer's  
Klutz?s capillaries always at greater risk
Lawrence Journal World, KS -
I miss those Cabbage Patch melees of 1983. It?s just that I bruise too easily to be in the game. For as long as I can remember, my limbs have been peppered ...
Hector Elizondo: Caring for a Loved One with Alzheimer's Dementia
HispanicBusiness.com (press release), CA - Nov 21, 2008
... such as the Exelon(R)Patch (rivastigmine transdermal system), which is the first and only skin patch for the treatment of mild to moderate Alzheimer's ...
Make the pain go away
Hagerstown Morning Herald, MD - Nov 25, 2008
Other new treatments, according to the NHF, include a battery-operated skin patch that allows migraine drugs to be absorbed into the body. ...
Chapter 9: Tracking the monster leads me north to Illinois
Jackson Clarion Ledger, MS - Nov 15, 2008
In December, she donated a patch of skin to Dr. Kimonis' research for more tests on the family disease. A smile crosses her face. "Guess who's in line to be ...
Source: Google News


 

Recent News and Articles on the Keywords: patch + alzheimers + skin  Related to the article below (Last Update: 8/7/2008)

Skin patch helps reduce woman's affair paranoia
Electric New Paper, Singapore - Jul 24, 2008
He prescribed a medicated patch (Exelon Patch), the only skin patch approved for the treatment of mild to moderately severe Alzheimer's dementia here. ...
Dementia Patients Tolerate Switch From Oral Donepezil to ...
DG News - Jul 29, 2008
[Presentation title: Results of a Two-Step Crossover Study of Donepezil (Aricept) to Rivastigmine Patch (Exelon Patch) in Alzheimer's Disease Patients: A ...

AsiaOne
Drug patch could make life easier for Alzheimer's patients
AsiaOne, Singapore - Jul 24, 2008
Approved last year in Europe and the United States, the Exelon patch is the only skin patch for the treatment of the disease's symptoms, Novartis said. ...
Health briefs
Tampabay.com, FL - Aug 4, 2008
The Mole Patrol, a team of skin cancer specialists from Moffitt Cancer Center, will provide free skin cancer screenings from 9 am to 3 pm Saturday at Pier ...
Novartis Gains Momentum With Strong Performance In First Half Of ...
ABN Newswire (press release), Australia - Jul 16, 2008
Exelon/Exelon Patch (USD 391 million, +20% lc), a therapy for mild to moderate forms of Alzheimer's disease and dementia linked with Parkinson's disease, ...NVS
Nation/World briefs
DetNews.com, MI - Jul 28, 2008
McCain has patch of skin removed: Republican Sen. John McCain said Monday he had a small patch of skin removed from his face and biopsied as part of a ...
Nation and world in brief
New Mexican, NM - Jul 28, 2008
John McCain said Monday that he had a small patch of skin removed from his face and biopsied as part of a regular checkup with his dermatologist. ...
Billy Graham is a Devil Worshipper!
Indymedia Venezuela, Venezuela - Aug 4, 2008
The cracked skin between the toes is how I have always experienced "Athlete's Foot" and that doesn't sound anything like a fungus at all. ...

In order to show you the most relevant results, we have omitted some entries very similar to the 8 already displayed.
If you like, you can repeat the search with the omitted results included.

Source: Google News

Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease -
HK White, ED Levin - Psychopharmacology, 1999 - Springer
... in Alzheimer?s disease patients (Sahakian et al. 1989; Sahakian and Jones 1991;
Jones et al. 1992) and other studies showing nicotine skin patch induced ...

… : A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease -
B Winblad, G Grossberg, L Frolich, M Farlow, S … - Neurology, 2007 - AAN Enterprises
... of Neurology IDEAL. A 6-month, double-blind, placebo-controlled study of
the first skin patch for Alzheimer disease. B. Winblad, MD ...

… , placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus … -
B Winblad, J Cummings, N Andreasen, G Grossberg, M … - Int J Geriatr Psychiatry, 2007 - ncbi.nlm.nih.gov
... Scale-Cognitive subscale (ADAS-Cog) and Alzheimer's Disease Cooperative ... nausea in
the 10 cm2 patch and capsule ... Moderate or severe skin irritation occurred in<or ...

Development of a novel prolonged-release nicotine transdermal patch -
S Davaran, MR Rashidi, R Khandaghi, M Hashemi - Pharmacological Research, 2005 - Elsevier
... [9] HK White and ED Levin, Four week nicotine skin patch treatment effects on cognitive
performance in Alzheimer's diseases, Psychopharmacology 143 (1999), pp. ...

Development of nicotinic drug therapy for cognitive disorders -
ED Levin, AH Rezvani - European Journal of Pharmacology, 2000 - Elsevier
... Fig. 2. Nicotine skin patch effects on CPT Alzheimer?s disease patients.
2.3. Schizophrenics. The great majority (about 80%) of ...

Physostigmine for dementia due to Alzheimer's disease (Cochrane Review)
JM Coelho Filho, J Birks - The Cochrane Database of Systematic Reviews, 2001 - update-software.com
... effectiveness of physostigmine for the symptomatic treatment of Alzheimer's disease ...
most recently a controlled-release (CR) oral formulation, and a skin patch. ...

Pharmacokinetics of a Rivastigmine Transdermal Patch Formulation in Healthy Volunteers: Relative … -
G Lefevre, G Sedek, HLA Huang, M Saltzman, M … - The Journal of Clinical Pharmacology, 2007 - jcp.sagepub.com
... the treatment of mild to moderate Alzheimer's disease (AD ... 3) to investigate how patch
adhesiveness at ... to investigate the potential for skin irritation induced ...

Physostigmine for Alzheimer's disease. -
F Coelho, J Birks - ncbi.nlm.nih.gov
... problem, most recently a controlled-release (CR) oral formulation, and a skin patch. ...
of beneficial effects for the use of physostigmine in Alzheimer's disease. ...

FDA Approves Transdermal Patch for Alzheimer's, Parkinson's Dementia -
J Yan - Psychiatric News, 2007 - Am Psychiatric Assoc
... Parkinson's Dementia. Jun Yan A new skin patch could make it easier for Alzheimer
patients and caregivers to take rivastigmine treatment. ...

Rivastigmine transdermal patch: a guide to its use in dementia of the Alzheimers type
I Blog - Drugs & Therapy Perspectives, 2008 - ingentaconnect.com
... IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch
for Alzheimer disease. Neurology 2007 Jul 24; 69 Suppl. 1: S14-22 ...

Source: Google Scholar
 
 

Alzheimer's skin patch 'reduces drug side effects'

Alzheimer's patients may soon be given a tried and tested drug through a skin patch to treat the creeping brain degeneration.

The patch infuses the drug Exelon through the patient's skin. "It would be good to have an alternative" to oral medication, said research leader Dr Bengt Winblad of Sweden's Karolinska Institute, who led the patch research. "It's a useful approach, a new treatment strategy that would be very appreciated not only by the patients, but the caregivers."

Alzheimer's affects 500,000 people in the UK. It gradually robs sufferers of their memories and ability to care for themselves, eventually killing them.

 

There is no known cure or prevention; today's drugs only temporarily treat symptoms. Exelon does that by inhibiting the breakdown of a brain chemical called acetylcholine, which is vital for nerve cells to communicate with each other. The longer acetylcholine sticks around, the longer those cells can call up memories.

But it can be hard to get Alzheimer's patients to swallow pills, and Exelon can cause serious nausea and vomiting. Applied once a day, the new skin patch sends Exelon straight into the bloodstream, bypassing the gastrointestinal tract in hopes of fewer side effects, and maintaining a consistent daylong dose.

The Novartis-funded study found the low-dose patch was just as effective as the high-dose pills - but pill users suffered three times more nausea and vomiting than patch users.

The patch headlines a trio of innovative potential treatments unveiled Wednesday at an international Alzheimer's meeting.

Also under study are a prostate cancer drug that may also help dementia and an immune therapy to ward off the sticky gunk that is Alzheimer's brain-clogging hallmark.

 
Google
Web www.iconocast.com
 
 

 

Continue News With: News9A ;

 

 

ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords:

Contact Iconocast

Home Page